Zobrazeno 1 - 4
of 4
pro vyhledávání: '"DMPM, diffuse malignant peritoneal mesothelioma"'
Autor:
Bernhard Biersack
Publikováno v:
Non-coding RNA Research, Vol 3, Iss 4, Pp 161-173 (2018)
Non-coding RNA Research
Non-coding RNA Research
Malignant mesothelioma diseases feature an increasing risk due to their severe forms and their association with asbestos exposure. Platinum(II) complexes such as cisplatin and carboplatin are clinically approved for the therapy of mesothelioma often
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5cf66f02600358bbd458691c22858d9
http://www.sciencedirect.com/science/article/pii/S2468054018300763
http://www.sciencedirect.com/science/article/pii/S2468054018300763
Autor:
Bernhard Biersack
Publikováno v:
Non-coding RNA Research
Non-coding RNA Research, Vol 3, Iss 4, Pp 213-225 (2018)
Non-coding RNA Research, Vol 3, Iss 4, Pp 213-225 (2018)
Gemcitabine and pemetrexed are clinically approved antimetabolites for the therapy of mesothelioma diseases. These drugs are often applied in combination with platinum complexes and other drugs. The activity of antimetabolites depended on the express
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f4aef9ba27f26bc625d6368297e1e44
http://europepmc.org/articles/PMC6257890
http://europepmc.org/articles/PMC6257890
Autor:
Biersack B; Organic Chemistry Laboratory, University of Bayreuth, Universitätsstraße 30, 95447, Bayreuth, Germany.
Publikováno v:
Non-coding RNA research [Noncoding RNA Res] 2018 Nov 04; Vol. 3 (4), pp. 213-225. Date of Electronic Publication: 2018 Nov 04 (Print Publication: 2018).
Autor:
Biersack B; Organic Chemistry Laboratory, University of Bayreuth, Universitätsstraße 30, 95447, Bayreuth, Germany.
Publikováno v:
Non-coding RNA research [Noncoding RNA Res] 2018 Aug 30; Vol. 3 (4), pp. 161-173. Date of Electronic Publication: 2018 Aug 30 (Print Publication: 2018).